Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

CUSIP: 03879J100

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Shares, without par value
Shares outstanding
193,679,354
Total 13F shares
78,913,089
Share change
+4,244,560
Total reported value
$197,297,266
Put/Call ratio
92%
Price per share
$2.50
Number of holders
110
Value change
+$10,900,831
Number of buys
45
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q4 2023

As of 31 Dec 2023, Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 78,913,089 shares. The largest 10 holders included Whitefort Capital Management, LP, BlackRock Inc., Two Seas Capital LP, MORGAN STANLEY, VANGUARD GROUP INC, Woodline Partners LP, Hudson Bay Capital Management LP, ADAR1 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 110 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.